Market Cap

Biohaven Pharmaceutical Holding Company Ltd. Market Capitalization:

$1.68 Billion

USD as of July 1, 2023

business Biohaven Pharmaceutical Holding Company Ltd. Company Profile

No stock data available

Market Capitalization History of Biohaven Pharmaceutical Holding Company Ltd.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $309.91 B
Vertex Pharmaceuticals Incorporated $117.36 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $59.14 B
Marinomed Biotech AG $58.56 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of Biohaven Pharmaceutical Holding Company Ltd. market cap

Date Market Cap YoY Change
Jan. 1, 2023 $1.27 B -85.93%
Jan. 1, 2022 $9.06 B 55.91%
Jan. 1, 2021 $5.81 B 75.75%
Jan. 1, 2020 $3.31 B 27.30%
Jan. 1, 2019 $2.60 B 10.21%
Jan. 1, 2018 $2.36 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Biohaven Pharmaceutical Holding Company Ltd. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.